Provident Healthcare Partners Advises Mid-Florida Endodontics on its Partnership with SRM Equity Partners

2 weeks ago

BOSTON and NEW YORK, Dec. 19, 2024 /PRNewswire/ -- Provident Healthcare Partners ("Provident"), a leading healthcare investment banking firm, announced…

Caris Life Sciences Exceeds 1,000 Published Studies Milestone

2 weeks ago

IRVING, Texas, Dec. 19, 2024 /PRNewswire/ -- Caris Life Sciences® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer,…

1099 Form Filing: New 2024 ez1099 Version Software from Halfpricesoft.com with Bulk Form Printing

2 weeks ago

REDMOND, Wash., Dec. 19, 2024 /PRNewswire/ -- Business owners and tax professionals get a jump on the 2025 tax season…

Lexaria’s Registered GLP-1 Study #4 Begins Dosing

2 weeks ago

Registered Phase-1b 12-week study will investigate safety, diabetes control, and weight loss KELOWNA, BC / ACCESSWIRE / December 19, 2024…

Zepbound Coupons and Discounts From Duty Free Meds

2 weeks ago

Duty Free Meds is proud to introduce a new Zepbound coupon offering to help lower patient costs associated with the…

Zepbound Coupons and Discounts From Duty Free Meds

2 weeks ago

Duty Free Meds is proud to introduce a new Zepbound coupon offering to help lower patient costs associated with the…

Jaguar Health Announces Import of Coca Leaf From Peru by Joint Venture Magdalena Biosciences for Research in Treating Mental Health Indications

2 weeks ago

Magdalena to explore coca leaf's possible therapeutic benefit for treatment of potentially ADHD or other neuropsychiatric indicationsThe import was conducted…

Rising From the Ashes: Ivy en Rose MedSpa Reopens in San Francisco, Exemplifying Strength and Community Spirit

2 weeks ago

Beloved MedSpa Overcomes Devastating Fire and Challenges to Continue Serving the Bay Area SAN FRANCISCO, CALIFORNIA / ACCESSWIRE / December…

MIRA Pharmaceuticals Submits IND for Ketamir-2 to FDA, Marking a Significant Milestone in the Company’s Pipeline Development

2 weeks ago

MIAMI, FL / ACCESSWIRE / December 19, 2024 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a preclinical-stage pharmaceutical company focused on developing…

NLS Pharmaceutics and Kadimastem Announce the Submission of a Request by Kadimastem and iTolerance, Inc. for an FDA Pre-IND Meeting for an Innovative Breakthrough Type 1 Diabetes Treatment

2 weeks ago

This submission comes after successful INTERACT meeting with the FDA earlier this year.NLS Pharmaceutics and Kadimastem working to close merger…